A phase 2 trial of iparomlimab and tuvonralimab, trifluridine/tipiracil and bevacizumab (glioblastoma use) in colorectal cancer, run by Jinan Central Hospital, not yet recruiting.
Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC is a phase 2, interventional study registered as NCT07116577 by Jinan Central Hospital, with a registry enrolment figure of 37 participants, started 2025-08-31 and due to reach its primary completion in 2027-08-31. Interventions recorded: Palliative radiotherapy; Iparomlimab and tuvonralimab; TAS-102; Bevacizumab. Conditions listed: mCRC. Primary outcome: ORR. Colorectal eligibility wording from the registry: "* Histologically confirmed unresectable colorectal adenocarcinoma". Sites: China. No results are recorded here; the registry entry is the source.
Shares Trifluridine/tipiracil, Bevacizumab (glioblastoma use), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Bevacizumab (glioblastoma use), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Bevacizumab (glioblastoma use), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Bevacizumab (glioblastoma use), Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Iparomlimab and tuvonralimab, Bevacizumab (glioblastoma use), IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Trifluridine/tipiracil, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.